HPI Effect in Robotic Urological Surgery on AKI
NCT: NCT06051162 · COMPLETED
Brief Summary
It is a single-center randomized controlled trial that aims to figure out the effect of the hypotension prediction index (HPI) on the prevention of acute kidney injury (AKI) after robot-assisted urological surgery. The primary hypothesis is that HPI software guidance prevents postoperative AKI by reducing the duration and severity of intraoperative hypotension (IOH).
Frequently Asked Questions
What is HPI Effect in Robotic Urological Surgery on AKI?
HPI Effect in Robotic Urological Surgery on AKI is a clinical trial registered under NCT06051162. Current status: COMPLETED.
What is the status of NCT06051162?
The current status of NCT06051162 (HPI Effect in Robotic Urological Surgery on AKI) is: COMPLETED.
When did HPI Effect in Robotic Urological Surgery on AKI start?
HPI Effect in Robotic Urological Surgery on AKI started on 2023-11-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.